US Patent 9447121 Triazine based radiopharmaceuticals and radioimaging agents
Patent 9447121 was granted and assigned to Molecular Insight Pharmaceuticals, Inc. on September, 2016 by the United States Patent and Trademark Office.
Is a
Current Assignee
Date Filed
January 10, 2014
Date of Patent
September 20, 2016
Patent Applicant
Patent Application Number
14152864
Patent Citations Received
Patent Jurisdiction
Patent Number
Patent Primary Examiner
Find more entities like US Patent 9447121 Triazine based radiopharmaceuticals and radioimaging agents
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
By using this site, you agree to our Terms of Service.